| Financial Year |
March 31 2023 |
| Monetary Funds |
97,051,095.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
407,805,230.13 |
| Advances to Suppliers |
3,102,352.27 |
| Other Receivables |
6,248,240.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
65,768.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,753,196.43 |
| Total Current Assets |
586,823,857.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,375,804.84 |
| Investment Properties |
516,957,877.23 |
| Fixed Assetes |
100,242,476.13 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,852,435.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,866,639.72 |
| Deferred Income Tax Assets |
14,195,134.03 |
| Other Non-Current Assets |
5,080,123.03 |
| Sub-Total of Non-Current Assets |
710,457,994.18 |
| Total Assets |
1,297,281,851.62 |
| Short-Term Loans |
124,480,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
198,291,356.87 |
| Accounts Received In Advance |
2,870,483.94 |
| Employee Compensation Payable |
14,407,966.06 |
| Taxes Payable |
6,183,191.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,125,431.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,254,902.63 |
| Other Current Liabilities |
28,384,146.17 |
| Sub-Total of Current Liabilities |
434,836,182.60 |
| Long-term Loans |
235,561,893.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
264,391.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
269,206,458.74 |
| Total Liabilities |
704,042,641.34 |
| Paid-In Capital(Or Share Stock) |
146,666,700.00 |
| Capital Surplus |
127,541,353.92 |
| Surplus Reserve |
25,500,328.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
255,096,120.43 |
| Minority Stockholder's Interest |
30,833,621.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
562,405,589.18 |
| Owner's Equity（Stockholder's Equity） |
593,239,210.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,297,281,851.62 |
